Direct-acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence after Local-Regional Therapy or Liver Transplant Waitlist Dropout

Whether direct-acting antivirals (DAA) increase the risk of hepatocellular carcinoma (HCC) recurrence after tumor-directed therapy is controversial. We sought to determine the impact of DAA therapy on HCC recurrence after local-regional therapy (LRT) and waitlist dropout among liver transplant (LT)...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hepatology
Hlavní autoři: Huang, Annsa C., Mehta, Neil, Dodge, Jennifer L., Yao, Francis Y., Terrault, Norah A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6097892/
https://ncbi.nlm.nih.gov/pubmed/29476694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.29855
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky